Lead-in placebo washout period.
Volavka
J
J
D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D008657:Metabolic Clearance Rate / Q000502:physiology; D018967:Risperidone / Q000008:administration & dosage* / Q000493:pharmacokinetics; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D018967:Risperidone